Sustained measles transmission in 2026, driven by declining childhood vaccination coverage and multiple ongoing outbreaks, forms the core driver of trader sentiment on total U.S. cases by August 31. As of August 6, the CDC reported 2,465 confirmed cases for the year—already exceeding the full 2025 total—with 94% linked to outbreaks and 93% occurring in unvaccinated individuals. Recent weekly increments of 24–78 cases reflect persistent community spread, particularly in states such as Utah and Pennsylvania. Official surveillance updates from the CDC, alongside any shifts in state-level reporting or vaccination campaigns, represent the key near-term data releases that could influence case trajectories before the August 31 cutoff.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado¿Casos de sarampión en EE. UU. antes del 31 de agosto?
¿Casos de sarampión en EE. UU. antes del 31 de agosto?
NUEVO
31 ago 2026
2500+
98%
2550+
94%
2600+
86%
$7,636 Vol.
2500+
$417 Vol.
98%
2550+
$932 Vol.
94%
2600+
$3,344 Vol.
86%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained measles transmission in 2026, driven by declining childhood vaccination coverage and multiple ongoing outbreaks, forms the core driver of trader sentiment on total U.S. cases by August 31. As of August 6, the CDC reported 2,465 confirmed cases for the year—already exceeding the full 2025 total—with 94% linked to outbreaks and 93% occurring in unvaccinated individuals. Recent weekly increments of 24–78 cases reflect persistent community spread, particularly in states such as Utah and Pennsylvania. Official surveillance updates from the CDC, alongside any shifts in state-level reporting or vaccination campaigns, represent the key near-term data releases that could influence case trajectories before the August 31 cutoff.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercado abierto: Jul 31, 2026, 10:25 AM ET
Volumen
$7,636Fecha de finalización
31 ago 2026Mercado abierto
Jul 31, 2026, 10:25 AM ETResolver
0x65070BE91...Resultado propuesto: Sí
Sin disputa
Resultado final: Sí
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained measles transmission in 2026, driven by declining childhood vaccination coverage and multiple ongoing outbreaks, forms the core driver of trader sentiment on total U.S. cases by August 31. As of August 6, the CDC reported 2,465 confirmed cases for the year—already exceeding the full 2025 total—with 94% linked to outbreaks and 93% occurring in unvaccinated individuals. Recent weekly increments of 24–78 cases reflect persistent community spread, particularly in states such as Utah and Pennsylvania. Official surveillance updates from the CDC, alongside any shifts in state-level reporting or vaccination campaigns, represent the key near-term data releases that could influence case trajectories before the August 31 cutoff.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$7,636Fecha de finalización
31 ago 2026Mercado abierto
Jul 31, 2026, 10:25 AM ETResolver
0x65070BE91...Resultado propuesto: Sí
Sin disputa
Resultado final: Sí
Sustained measles transmission in 2026, driven by declining childhood vaccination coverage and multiple ongoing outbreaks, forms the core driver of trader sentiment on total U.S. cases by August 31. As of August 6, the CDC reported 2,465 confirmed cases for the year—already exceeding the full 2025 total—with 94% linked to outbreaks and 93% occurring in unvaccinated individuals. Recent weekly increments of 24–78 cases reflect persistent community spread, particularly in states such as Utah and Pennsylvania. Official surveillance updates from the CDC, alongside any shifts in state-level reporting or vaccination campaigns, represent the key near-term data releases that could influence case trajectories before the August 31 cutoff.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes